The Relationship between Placenta Location with Occurrence of Pre-Eclampsia: A Single Centre Study in Port Harcourt, Nigeria
Asian Journal of Pregnancy and Childbirth,
Background:Over the years, several screening tests have been developed, yet none is clinically useful for the prediction of pre-eclampsia. Currently, biochemical and biophysical markers of abnormal placentation are being studied as a link to the pathogenesis of pre-eclampsia.
Objectives: The aim of the study was to determine the relationship between the type of placentalocation determined by the use of ultrasound scan and occurrence of pre-eclampsia.
Methodology: The study was carried out at the department of Obstetrics and Gynaecology of the University of Port Harcourt Teaching Hospital (UPTH). Women admitted with the diagnosis of pre-eclampsia as well as those without pre-eclampsia at 28 to 42 weeks of gestation who satisfied the eligibility criteria, and consented for the study were enrolled. A structured proforma was used to obtain relevant information from the participants. Data was entered and analysed with SPSS Statistics for windows, version 20. Results were presented infrequency tables. Chi square and student ‘t’ test were used to respectively compare discrete and continuous variables with p value < 0.05 set as significant.
Results: The results showed that majority 41 (75%) of women with pre-eclampsia had the severe form of the disorder and majority 35 (65%) were referrals from peripheral health centres. Generally, the most common 42 (38.2%) placenta location was anterior placenta. The majority 26 (47.27%) of womenwithout pre-eclampsia had anterior placenta and the relationship was significant, p = 0.0049, (OR 0.45; 95% CI 0.20 – 1.00). While the majority 18 (32.73%)of women with pre-eclampsia had posterior placenta, p = 0.1298, (OR 1.94; 95% CI: 0.81 – 4.63). Lateral placenta was observed in 9 (16.3%) of women with pre-eclampsia, and the association with pre-eclampsia was significant, p = 0.0017.
Conclusion: Ultrasound location of the placenta is relatively safe and cost effective. Lateral placenta may be another risk factor for pre-eclampsia and its detection may raise the index of suspicion for the risk of pre-eclampsia. This may enhance early and prompt institution of preventive measures in order to improve outcome.
- Placenta location
- Port Harcourt.
How to Cite
Osungbade KO, Ige OK. Public health perspective of pre-eclampsia in developing countries: Implication for health system strengthening. J Pregnancy. 2011;2011:1-6.
Dolea C, AbouZahr C. Global burden of hypertensive disease of pregnancy in the year 2000. Evidence and information for policy. World Health Organization. 2003;1-11.
Ugwu E, Dim CC, Okonkwo CD, Nwankwo TO. Maternal and perinatal outcome of severe pre-eclampsia in Enugu, Nigeria after introduction of magnesium sulphate. Niger J Clin Pract. 2011;14(4):418- 21.
Onyiriuka AN, Okolo AA. Perinatal outcome in patients with pre-eclampsia in Benin City, Nigeria. Trop J Obstet Gynecol. 2004;21:148-52.
Say L, Chou D, Gemmill A, Tuncalp O, Moller AB, Daniel J et al. Global causes of maternal death: A systematic analysis. Lancet Global Health. 2014;2(6):323-33.
WHO. World Health statistics. Geneva, World Health Organization;2014.
Uzoigwe SA, John CT. Maternal mortality in the university of Port-Harcourt Teaching Hospital, Port-Harcourt in the last year before the millennium. Niger J Med. 2004;13(1):32 – 5.
Conde-Agudelo A, Belizan JM. Risk factors for pre-eclampsia in a large cohort Latin American and Carribean women. BJOG. 2000;107(1):75 – 83.
Akolekar R, Syngelaki A, Poon L, Nicolaides KH. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagnosis and Therapy. 2013;33(1):8 – 15.
Conde-Agudelo A, Villar J, Lindheimer M.World Health Organization systemic review of screening tests for pre-eclampsia. Obstet Gynecol. 2004;104 (6):1367 – 91.
Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. First trimester prediction of hypertensive disorders of pregnancy. Hypertension. 2009;53:812 – 18.
Gonser M, Tillack N, Pfeiffer KH, Mielke G. Placental location and incidence of pre-eclampsia. Ultraschall Med. 1996;17(5): 236 – 8.
Kirkwood BR, Sterne JAC. Calculation of required sample sizes. Essential medical statistics, 2nd Edition. United Kingdom, Blackwell Science. 2003;420 – 1.
The University of Port Harcourt Teaching Hospital, Obstetrics and Gynaecology Department Annual Report. (Unpublished Data); 2015.
Adam I, Haggaz A, Mirghani OA, Elhassan EM. Placenta praevia and pre-eclampsia: Analysis of 1645 cases at Medani Maternity Hospital, Sudan. Front. Physiol. 2013;4:32.
Ananth CV, Bowes WA, Savitz DA, Luther ER. Relationship between pregnancy-induced hypertension and placenta praevia: A population-based study. AJOG. 1997;177(5):997-1002.
Jelsema RD, Bhatia RK, Zador IE, Bottoms SF, Sokol RJ. Is placenta praevia a determinant of pre-eclampsia? J Perinat Med. 1991;19(6):485
Kakkar T, Singh V, Razdan R, Digra SK, Gupta A, Kakkar M. Placental laterality as a predictor for development of pre-eclampsia. J ObstetGynaecol India. 2013; 63(1):22 – 5.
Bhalerao AV, Kulkarni S, Somalwar S. Lateral placentation by ultrasonography: A simple predictor of preeclampsia. J South Asian Feder Obst Gynae. 2013;5(2):68–71.
Kirkwood BR, Sterne JAC. Calculation of required sample sizes. Essential Medical Statistics, 2nd Edition. United Kingdom, Blackwell Science. 2003;420 – 1.
Duckitt K, Harrington D. Risk factors for preeclampsia at antenatal booking: Systemic review of controlled studies. BMJ. 2005;330(7491): 565.
Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. Am J Obstet Gynecol. 2004; 190:1520 – 6.
Torricelli M, Vannuccini S, Moncini I, Cannoni A, Voltolini C, Conti N et al. Anterior placental location influences onset and progress of labor and postpartum outcome. Placenta. 2015;36(4):463 – 6.
Abstract View: 40 times
PDF Download: 20 times